Close Menu

NEW YORK (GenomeWeb) – Almac Diagnostics today announced a collaboration with Illumina to establish a framework for developing next-generation sequencing-based companion diagnostic assays.

Under the terms of the agreement, UK-based Almac will be able to develop NGS assays using the Illumina MiSeqDx instrument. The MiSeqDx is the first NGS instrument to be cleared by the US Food and Drug Administration for in vitro diagnostic purposes in clinical laboratories.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research. 

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.